ID   BY00877
AC   CVCL_G792
DR   IPD-IMGT/HLA; 25477
DR   Wikidata; Q54799676
RX   PubMed=21995494;
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:FTZP,11:FEXH; B*35:08:01,41:14; DRB1*11:04,07:01 (IPD-IMGT/HLA=25477).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
RX   PubMed=21995494; DOI=10.1111/j.1399-0039.2011.01788.x;
RA   Lazaro A.M., Henry J., Ng J., Hurley C.K., Posch P.E.;
RT   "Increased HLA class I and II diversity as 72 novel alleles are
RT   identified in volunteers for the National Marrow Donor Program
RT   Registry in 2010.";
RL   Tissue Antigens 79:50-57(2012).
//
RX   PubMed=22077627; DOI=10.1111/j.1399-0039.2011.01792.x;
RA   Marsh S.G.E.;
RG   WHO Nomenclature Committee for Factors of the HLA System;
RT   "Nomenclature for factors of the HLA system, update August 2011.";
RL   Tissue Antigens 78:474-481(2011).
//